Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Ustekinumab, Treatment for Plaque Psoriasis by Centocor and Janssen-Cilag

A variety of tools have been used to assess the severity of plaque psoriasis and response to treatment, some of which are detailed above. The PASI, which provides a measure of the average redness, thickness and scaliness of the lesions, is the current gold standard for assessing response to treatment.

Go Top